BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 10362016)

  • 21. Senescence and immortalization: role of telomeres and telomerase.
    Shay JW; Wright WE
    Carcinogenesis; 2005 May; 26(5):867-74. PubMed ID: 15471900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomerase and human tumorigenesis.
    Stewart SA; Weinberg RA
    Semin Cancer Biol; 2000 Dec; 10(6):399-406. PubMed ID: 11170862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomerase activity does not always imply telomere maintenance.
    Ouellette MM; Aisner DL; Savre-Train I; Wright WE; Shay JW
    Biochem Biophys Res Commun; 1999 Jan; 254(3):795-803. PubMed ID: 9920820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase allows the immortalization of T antigen-positive DMD myoblasts: a new source of cells for gene transfer application.
    Seigneurin-Venin S; Bernard V; Tremblay JP
    Gene Ther; 2000 Apr; 7(7):619-23. PubMed ID: 10819578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
    Sun B; Chen M; Hawks CL; Hornsby PJ
    Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
    Fasching CL; Bower K; Reddel RR
    Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to apoptosis in human cells conferred by telomerase function and telomere stability.
    Holt SE; Glinsky VV; Ivanova AB; Glinsky GV
    Mol Carcinog; 1999 Aug; 25(4):241-8. PubMed ID: 10449030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strict control of telomerase activation using Cre-mediated inversion.
    Ungrin MD; Harrington L
    BMC Biotechnol; 2006 Feb; 6():10. PubMed ID: 16504006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple levels of telomerase regulation.
    Stewart SA
    Mol Interv; 2002 Dec; 2(8):481-3. PubMed ID: 14993399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of telomerase in cellular proliferation and cancer.
    Holt SE; Shay JW
    J Cell Physiol; 1999 Jul; 180(1):10-8. PubMed ID: 10362013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres.
    Goodwin EC; DiMaio D
    Cell Growth Differ; 2001 Nov; 12(11):525-34. PubMed ID: 11714633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic changes associated with immortalization. A review.
    Duncan EL; Reddel RR
    Biochemistry (Mosc); 1997 Nov; 62(11):1263-74. PubMed ID: 9467850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term molecular and cellular stability of human neural stem cell lines.
    Villa A; Navarro-Galve B; Bueno C; Franco S; Blasco MA; Martinez-Serrano A
    Exp Cell Res; 2004 Apr; 294(2):559-70. PubMed ID: 15023542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines.
    Schwartz JL; Jordan R; Liber H; Murnane JP; Evans HH
    Genes Chromosomes Cancer; 2001 Mar; 30(3):236-44. PubMed ID: 11170280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomere length dynamics in telomerase-positive immortal human cell populations.
    Bryan TM; Englezou A; Dunham MA; Reddel RR
    Exp Cell Res; 1998 Mar; 239(2):370-8. PubMed ID: 9521855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomeres and telomerase in sarcomas.
    Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
    Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase-immortalized sheep fibroblasts can be reprogrammed by nuclear transfer to undergo early development.
    Cui W; Wylie D; Aslam S; Dinnyes A; King T; Wilmut I; Clark AJ
    Biol Reprod; 2003 Jul; 69(1):15-21. PubMed ID: 12606403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
    Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
    Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Termination of lifespan of SV40-transformed human fibroblasts in crisis is due to apoptosis.
    Macera-Bloch L; Houghton J; Lenahan M; Jha KK; Ozer HL
    J Cell Physiol; 2002 Mar; 190(3):332-44. PubMed ID: 11857449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.